Skip to content

Influenza Virus Genotyping (Serum/Plasma)

Published: August 9, 2026Updated: August 16, 2026

This test identifies specific genetic sequences of the influenza virus to help determine which strains may be most effective to target with antiviral treatments or vaccines.

Quick summary

["Genotyping helps tailor treatment and prevention strategies for influenza infections."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
57895-5
Short code
FLUAV H1 NI resis Spec Genotyp
Synonyms
FLUAV H1 NI resis Spec Genotyp
Category
chemistry
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
genotyping
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

Why This Test Is Done

Your healthcare provider may order this test if you have symptoms of the flu (such as fever, cough, or body aches) and suspect an influenza infection. Genotyping can also be used in research or outbreak investigations to track virus spread and guide public health responses.

What to Expect Before the Test

No special preparation is needed. A blood sample will be drawn from a vein in your arm. You may feel a slight pinch, but the process is quick and usually not painful. If you’re on blood-thinning medication, let your provider know before the test.

How the Test Works

The test involves analyzing a small amount of your serum or plasma to detect specific genetic fragments (nucleic acid sequences) of the influenza virus. Advanced laboratory techniques, such as polymerase chain reaction (PCR) or sequencing, are used to identify these sequences.

What the Results Mean

Results show which genetic variants of the influenza virus are present. These variants help healthcare providers determine the most appropriate antiviral medications or vaccines to treat or prevent infection, especially in cases where standard treatments may not be effective.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Genotyping influenza viruses is critical for guiding personalized treatment plans, especially in high-risk patients (e.g., those with chronic illnesses or weakened immune systems). It also supports public health efforts by identifying emerging strains, helping to adjust vaccination strategies, and monitoring outbreaks.

Frequently asked questions

What does a positive result mean?
A positive result confirms the presence of a specific influenza virus strain in your blood. This doesn’t indicate which symptoms you’re experiencing but helps your doctor choose the best antiviral treatment or vaccination approach.
How long does it take to get results?
Results are typically available within 1–3 business days, depending on lab processing times. Your healthcare provider will contact you once they have the findings.
Can this test be done at home?
No, this test requires a blood sample collected by a healthcare professional in a clinical setting. Home test kits are not available for this specific genotyping procedure.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy